Krachler B, Savonen K, Komulainen P, Hassinen M, Lakka TA, Rauramaa R
If you are committing to a full protocol of 812 sessions, the effective cost per session comes down meaningfully
For those living with lipedema, managing symptoms and improving quality of life often requires a comprehensive approach, including specialized surgical solutions, dietary changes, and tailored medical treatments
The references in Table 2 can be found in our paper
Metabolic enhancement (3-6 months) This is when things get really exciting
Key players in Chiles GLP-1 segment: Novo Nordisk Market leader with Ozempic, Victoza, and Wegovy Eli Lilly Bringing innovation with Mounjaro (Tirzepatide) Sanofi Providing Soliqua, a GLP-1 + insulin combo CFR Pharmaceuticals (Abbott) Local affiliate with strong market access Biocon Expanding biosimilar reach in Latam AstraZeneca Strategic focus on metabolic & cardiovascular synergy With increasing physician adoption and patient demand, Chile is evolving into a high-opportunity market for obesity and type 2 diabetes therapies
